Throughout its history, EORTC has been instrumental in several major advancements in cancer treatment. The organization has contributed to the development of chemotherapy regimens, targeted therapies, and immunotherapies that have become standard treatments for various cancers. EORTC has also pioneered research in quality of life assessments, ensuring that the impact of cancer treatments on patients' daily lives is considered alongside survival outcomes. These achievements have significantly influenced cancer care guidelines and policies globally.
